Alpha 2.0
Login Register
» Articles » PMID: 7742288

Microbial Contamination of Medications Used to Treat Glaucoma

Overview
Journal Br J Ophthalmol
Specialty Ophthalmology
Date 1995 Apr 1
PMID 7742288
Citations 41
Authors
O Geyer
E J Bottone
S M Podos
R A Schumer
P A Asbell
Affiliations
Soon will be listed here.
Abstract

Aims: A study was conducted to estimate the frequency of contamination of topical antiglaucoma medications used by asymptomatic patients.

Methods: The drops and the bottle tips of 194 in use topical medications and the conjunctiva from 109 treated glaucoma patients were cultured.

Results: Bacteria were recovered from 55 (28%) medications. The bottle tip was more frequently contaminated than the drops (p = 0.008). Gram positive organisms were cultured from 50 (91%) of 55 contaminated medications. Thirteen patients (12%) had the same microorganism recovered from the conjunctiva and from the contaminated medication. The frequency of contamination of medications increased with increasing duration of use. Bacterial contamination occurred in 19% of eyedrops less than 8 weeks old in contrast with 40% of bottles used for more than 8 weeks.

Conclusion: Our data suggest that ocular medications to treat glaucoma frequently become contaminated with bacteria and that contamination is related to duration of use. We therefore recommend that opened topical antiglaucoma eyedrops should be replaced on a regular basis.

Citing Articles

Evaluating and Managing the Microbial Contamination of Eye Drops: A Two-Phase Hospital-Based Study.

Roquefeuil L, Iskandar K, Roques C, Marchin L, Guittard M, Poupet H Pharmaceutics. 2024; 16(7).

PMID: 39065630 PMC: 11279954. DOI: 10.3390/pharmaceutics16070933.

Microbial contamination of multiple-dose preservative-free hospital ophthalmic preparations in a tertiary care hospital.

Chantra S, Hathaisaard P, Grzybowski A, Ruamviboonsuk P Adv Ophthalmol Pract Res. 2023; 2(1):100046.

PMID: 37846225 PMC: 10577817. DOI: 10.1016/j.aopr.2022.100046.

Intraocular nano-microscale drug delivery systems for glaucoma treatment: design strategies and recent progress.

Shen Y, Sun J, Sun X J Nanobiotechnology. 2023; 21(1):84.

PMID: 36899348 PMC: 9999627. DOI: 10.1186/s12951-023-01838-x.

Highlighting the Microbial Contamination of the Dropper Tip and Cap of In-Use Eye Drops, the Associated Contributory Factors, and the Risk of Infection: A Past-30-Years Literature Review.

Iskandar K, Marchin L, Kodjikian L, Rocher M, Roques C Pharmaceutics. 2022; 14(10).

PMID: 36297611 PMC: 9611205. DOI: 10.3390/pharmaceutics14102176.

Knowledge, Attitudes, and Practices Toward Self-Medicating Eye Symptoms in Saudi Arabia.

Alessa D, AlHuthail R, Al Mahfud S, Alshngeetee A, Alruwaili S, Khalaf A Clin Ophthalmol. 2022; 16:723-731.

PMID: 35300034 PMC: 8921836. DOI: 10.2147/OPTH.S352964.

References
1.
Schein O, Wasson P, BORUCHOFF S, Kenyon K . Microbial keratitis associated with contaminated ocular medications. Am J Ophthalmol. 1988; 105(4):361-5. DOI: 10.1016/0002-9394(88)90298-x. View
2.
Perkins R, KUNDSIN R, Pratt M, Abrahamsen I, LEIBOWITZ H . Bacteriology of normal and infected conjunctiva. J Clin Microbiol. 1975; 1(2):147-9. PMC: 274990. DOI: 10.1128/jcm.1.2.147-149.1975. View
3.
MCNATT J, Allen S, Wilson L, Dowell Jr V . Anaerobic flora of the normal human conjunctival sac. Arch Ophthalmol. 1978; 96(8):1448-50. DOI: 10.1001/archopht.1978.03910060196020. View
4.
Aslund B, Olson O, SANDELL E . Studies on in-use microbial contamination of eye drops. Acta Pharm Suec. 1978; 15(5):389-94. View
5.
Templeton 3rd W, Eiferman R, Snyder J, Melo J, Raff M . Serratia keratitis transmitted by contaminated eyedroppers. Am J Ophthalmol. 1982; 93(6):723-6. DOI: 10.1016/0002-9394(82)90467-6. View